Stay informed with the latest updates for the inheritable blood disorders community. Industry UniQure Reaches Enrollment Goal in Phase 3 Gene Therapy TrialSep 6, 2019 Industry Investigational Marstacimab Shows Promise in Laboratory AssaysSep 3, 2019 Industry Sigilon’s SIG-001 Receives Orphan Drug Designation Aug 29, 2019 Further Response from Bayer on Kogenate® FS RecallAug 21, 2019 Industry New Lab Test Screens for Inhibitors in Patients Receiving Hemlibra®Aug 20, 2019 Medical Dedicated Hemotologist and Patient Advocate Dies at 95 Aug 20, 2019 Industry Analysis Compares Prophylaxis with Emicizumab vs FVIII ReplacementAug 14, 2019 Medical MASAC Issues New Document on Liver Biopsies in Gene TherapyAug 14, 2019 Bayer Releases New Statement on Kogenate FS RecallAug 12, 2019 Meet the Red Tie Runners!Aug 2, 2019 Bayer Responds to NHF-HFA Joint StatementJul 31, 2019 Industry Freeline Provides Updates on Hemophilia Gene Therapy ProgramsJul 29, 2019 Joint Statement on Recall of Bayer Kogenate® FS LotsJul 26, 2019 Industry Investigators Report Progress on New Subcutaneous TherapyJul 25, 2019 Industry Casebia Presents Dual Approach to Gene TherapyJul 23, 2019 Pagination First page Previous page … Page 35 Page 36 Page 37 Page 38 Current page 39 Page 40 Page 41 Page 42 Page 43 … Next page Last page